NCT06753214 Telemedicine Education for Caregivers and Asthma Control in Children
| NCT ID | NCT06753214 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Can Tho University of Medicine and Pharmacy |
| Condition | Uncontrolled Asthma |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2024-06-05 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2024-06-05 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Asthma control in pediatric patients remains a critical issue for healthcare providers. Telemedicine has emerged as an effective solution for overcoming distance barriers in healthcare delivery. This study aims to utilize telemedicine-based education for caregivers to improve asthma control in children with uncontrolled asthma. By providing remote guidance and support, the study seeks to enhance caregivers' knowledge and management practices, ultimately leading to better asthma outcomes for pediatric patients.
Eligibility Criteria
Inclusion Criteria: * Pediatric asthma patients diagnosed according to the GINA guidelines, classified as having uncontrolled asthma, are managed and followed up for at least 1 month at the pediatric asthma unit of the outpatient department. Exclusion Criteria: * Pediatric patients who do not cooperate or are unable to complete the Childhood Asthma Control Test questionnaire. * Caregivers who cannot complete the questionnaires related to the assessment of asthma control and associated factors. * Pediatric patients who have siblings participating in the study. * Patients currently participating in another clinical study (excluding non-interventional studies or registries). * Failure to return for a second visit within 6 months following enrollment.
Contact & Investigator
Nghia Quang Bui, MD, PhD
STUDY CHAIR
Can Tho University of Medicine and Pharmacy
Frequently Asked Questions
Who can join the NCT06753214 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 16 Years, studying Uncontrolled Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06753214 currently recruiting?
Yes, NCT06753214 is actively recruiting participants. Contact the research team at hoangthang0899@gmail.com for enrollment information.
Where is the NCT06753214 trial being conducted?
This trial is being conducted at Can Tho, Vietnam.
Who is sponsoring the NCT06753214 clinical trial?
NCT06753214 is sponsored by Can Tho University of Medicine and Pharmacy. The principal investigator is Nghia Quang Bui, MD, PhD at Can Tho University of Medicine and Pharmacy. The trial plans to enroll 64 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.